Association of insulin treatment with gastric residue during an esophagogastroduodenoscopy.
Association of insulin treatment with gastric residue during an esophagogastroduodenoscopy.
复制标题
DOI:
10.1111/jdi.13665
复制
发表时间:
2022-03
影响因子:
3.2
通讯作者:
Kasuga M
中科院分区:
文献类型:
--
作者:
Kobori T;Onishi Y;Iwamoto M;Kubota T;Kikuchi T;Tahara T;Takao T;Fujiwara H;Yoshida Y;Kasuga M
The purpose of this study was to investigate the association of glycemic control and diabetes treatment to gastric residue observed during an esophagogastroduodenoscopy. Among 6,592 individuals who had esophagogastroduodenoscopy at our clinic between 2003 and 2019, we retrospectively and longitudinally identified those who had gastric residue during an esophagogastroduodenoscopy. Other data collected were age, sex, diagnosis of diabetes, glycated hemoglobin and diabetes medication. Cox proportional hazards models were used to assess the association of these data with the occurrence of gastric residue. To the best of our knowledge, this is the first retrospective cohort study finding that undergoing insulin treatment is a risk factor for gastric residue independent of age, sex and diabetes or glycated hemoglobin. We showed in a retrospective cohort study that undergoing insulin treatment was a risk factor for gastric residue in an esophagogastroduodenoscopy independent of age, sex and diabetes or glycated hemoglobin. This is the first report investigating the association of insulin treatment and gastric residue observed during an esophagogastroduodenoscopy.
登录
查看更多内容
影响因子:
8.2
作者:
Tesfaye, S;Stevens, LK;Ward, JD
通讯作者:
Ward, JD
影响因子:
158.5
作者:
PARTANEN, J;NISKANEN, L;UUSITUPA, M
通讯作者:
UUSITUPA, M
影响因子:
5.8
作者:
Freemantle, N.;Balkau, B.;Home, P. D.
通讯作者:
Home, P. D.
影响因子:
5.8
作者:
Freemantle, N.;Balkau, B.;Home, P. D.
通讯作者:
Home, P. D.
影响因子:
2.9
作者:
Kim, Young Hwan;Seo, Eun Hee;Lee, Chang Won
通讯作者:
Lee, Chang Won